Previous 10 | Next 10 |
Gamida Cell Ltd. (GMDA) Q1 2020 Results Conference Call May 21, 2020 08:30 AM ET Company Participants Jaren Madden - Vice President, Investor Relations and Corporate Communications Julian Adams - CEO Ronit Simantov - Chief Medical Officer Shai Lankry - CFO Conference Call Pa...
Gamida Cell (NASDAQ: GMDA ): Q1 GAAP EPS of -$0.31 beats by $0.15 . More news on: Gamida Cell Ltd., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
– Primary endpoint achieved in global, randomized, Phase 3 study of omidubicel; Initiation of BLA submission planned for fourth quarter of 2020 — – Additional data from GDA-201 program expected in second half of 2020 – – $60 million follow-on of...
Gamida Cell (NASDAQ: GMDA ) -25% after pricing equity offering. More news on: Gamida Cell Ltd., Gossamer Bio, Inc., Bellerophon Therapeutics, Inc., Stocks on the move, , Read more ...
Gamida Cell (NASDAQ: GMDA ) prices 13,333,334 ordinary shares at a $4.50 per share for aggregate gross proceeds of ~$60M. More news on: Gamida Cell Ltd., Healthcare stocks news, , Read more ...
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to finding cures for blood cancers and serious blood diseases, today announced the pricing of an underwritten public offering of 13,333,334 ordinary shares at a public offering price of $4.50 per share for aggregate g...
Gainers: ABUS +46.5% . DAC +10.1% . TNP +9.1% . BIDU +8.9% . ACB +6.4% . More news on: Arbutus Biopharma Corporation, Danaos Corporation, Tsakos Energy Navigation Limited, Stocks on the move, , Read more ...
Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will host a conference call and live audio webcast on Thursday, May 21, 2020, at 8:30 a.m. ET to review its first quarter 2020 fi...
Vir Bio Moves Ahead with COVID Projects, Reports Higher Q1 Revenue Vir Biotechnology ( VIR ) provided an update about its COVID projects, while confirming GlaxoSmithKline's ( GSK ) investment worth $250 million. The company is currently working on multiple clinical programs to address C...
SIFCO (NYSEMKT: SIF ) +61% on Q2 results . More news on: SIFCO Industries, Inc., United Natural Foods, Inc., Cyclacel Pharmaceuticals, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Gamida Cell Ltd. Company Name:
GMDA Stock Symbol:
NASDAQ Market:
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney d...
2024-04-03 06:21:00 ET How to Analyze Different Penny Stocks Sectors to Make Money Investing in penny stocks offers an accessible entry point for individuals aiming to participate in the stock market with a lower initial investment. Analyzing different sectors within the realm of penn...
A look at the top 10 most actives in the United States Trio Petroleum Corp. (TPET) rose 43.8% to $0.1485 on volume of 202,621,744 shares Nikola Corporation (NKLA) fell 5.5% to $0.9736 on volume of 187,304,976 shares C3is Inc. (CISS) rose 13.3% to $0.0409 on volume of 136,767,990 shares ...